Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HUMAN RHO IMMUNE GLOBULIN: 1,207 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
1,207
Total FAERS Reports
24 (2.0%)
Deaths Reported
239
Hospitalizations
1,207
As Primary/Secondary Suspect
43
Life-Threatening
32
Disabilities
Kedrion Biopharma Inc
Manufacturer

Drug Class: Endogenous Antigen Neutralization [MoA] · Manufacturer: Kedrion Biopharma Inc ·

First Report: 19930430 · Latest Report: 20250920

What Are the Most Common HUMAN RHO IMMUNE GLOBULIN Side Effects?

#1 Most Reported
No adverse event
238 reports (19.7%)
#2 Most Reported
Drug ineffective
201 reports (16.7%)
#3 Most Reported
Device issue
167 reports (13.8%)

All HUMAN RHO IMMUNE GLOBULIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
No adverse event 238 19.7% 0 2
Drug ineffective 201 16.7% 6 77
Device issue 167 13.8% 0 1
Syringe issue 154 12.8% 0 1
Nausea 111 9.2% 7 19
Treatment failure 110 9.1% 6 88
Arthralgia 109 9.0% 6 74
Therapy non-responder 107 8.9% 7 77
Pain in extremity 104 8.6% 6 76
Therapeutic product effect decreased 104 8.6% 5 31
Joint swelling 100 8.3% 6 75
Infection 98 8.1% 6 74
Haemolysis 97 8.0% 1 6
Hepatotoxicity 96 8.0% 6 72
Musculoskeletal stiffness 96 8.0% 6 73
Condition aggravated 94 7.8% 7 74
Gastrointestinal toxicity 93 7.7% 6 72
Musculoskeletal pain 93 7.7% 6 72
Neoplasm malignant 93 7.7% 6 72
Joint injury 91 7.5% 6 71

Who Reports HUMAN RHO IMMUNE GLOBULIN Side Effects? Age & Gender Data

Gender: 85.3% female, 14.7% male. Average age: 32.5 years. Most reports from: US. View detailed demographics →

Is HUMAN RHO IMMUNE GLOBULIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 2 0 1
2004 2 0 2
2005 3 0 1
2006 3 0 0
2007 2 0 0
2008 5 2 3
2009 6 0 0
2010 1 0 0
2011 3 0 1
2012 1 0 0
2013 15 1 3
2014 32 2 8
2015 52 1 9
2016 37 0 8
2017 39 2 8
2018 36 1 4
2019 50 1 10
2020 47 0 10
2021 65 0 20
2022 17 0 4
2023 11 1 2
2024 29 0 4
2025 9 0 4

View full timeline →

What Is HUMAN RHO IMMUNE GLOBULIN Used For?

IndicationReports
Product used for unknown indication 385
Prophylaxis against rh isoimmunisation 138
Immune thrombocytopenic purpura 50
Rhesus antigen negative 44
Rhesus incompatibility 43
Immune thrombocytopenia 36
Prophylaxis 31
Alloimmunisation 26
Foetal-maternal haemorrhage 19
Pregnancy 17

HUMAN RHO IMMUNE GLOBULIN vs Alternatives: Which Is Safer?

HUMAN RHO IMMUNE GLOBULIN vs HUMIRA HUMAN RHO IMMUNE GLOBULIN vs HUMIRA PEN HUMAN RHO IMMUNE GLOBULIN vs HYALURONATE HUMAN RHO IMMUNE GLOBULIN vs HYALURONIC ACID HUMAN RHO IMMUNE GLOBULIN vs HYALURONIC ACID\LIDOCAINE HUMAN RHO IMMUNE GLOBULIN vs HYALURONIDASE HUMAN RHO IMMUNE GLOBULIN vs HYALURONIDASE-OCSQ\OCRELIZUMAB HUMAN RHO IMMUNE GLOBULIN vs HYALURONIDASE \RITUXIMAB HUMAN RHO IMMUNE GLOBULIN vs HYALURONIDASE-ZZXF\PERTUZUMAB\TRASTUZUMAB HUMAN RHO IMMUNE GLOBULIN vs HYDRALAZINE

Official FDA Label for HUMAN RHO IMMUNE GLOBULIN

Official prescribing information from the FDA-approved drug label.